Загрузка страницы

Patients Contract Rare Fungal Disease Mucormycosis | Coronavirus: Fact Vs Myth

Cases of COVID-19-triggered Mucormycosis fungus have been reported. Doctors explain the rare fungal disease and the risk factors associated with it.
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt

Видео Patients Contract Rare Fungal Disease Mucormycosis | Coronavirus: Fact Vs Myth канала NDTV
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
17 декабря 2020 г. 0:43:02
00:09:09
Другие видео канала
Moderna Covid-19 vaccine is 95% effective and could prevent further infectionModerna Covid-19 vaccine is 95% effective and could prevent further infectionMyco-Cinics 2: Covid-19 associated fungal infectionsMyco-Cinics 2: Covid-19 associated fungal infectionsThird Covid Wave: Health Minister Meets Officials Of 9 States, Flag 3 ConcernsThird Covid Wave: Health Minister Meets Officials Of 9 States, Flag 3 ConcernsNew Delhi: Mucormycosis surfaces as a rapidly growing rare fatal fungal diseaseNew Delhi: Mucormycosis surfaces as a rapidly growing rare fatal fungal diseaseNDTV 24x7 LIVE TV - Watch Latest News in English | Breaking NewsNDTV 24x7 LIVE TV - Watch Latest News in English | Breaking NewsCan You Get Covid After Vaccination? What Experts Say | Coronavirus: Facts Vs MythsCan You Get Covid After Vaccination? What Experts Say | Coronavirus: Facts Vs MythsThe Logistics Behind the U.S. Covid Vaccine Rollout | WSJThe Logistics Behind the U.S. Covid Vaccine Rollout | WSJStudy: First 10 days of COVID-19 victim after discharge from hospital crucial | Coronavirus StudyStudy: First 10 days of COVID-19 victim after discharge from hospital crucial | Coronavirus StudyCargo handler SATS invests S$1m in equipment to handle COVID-19 vaccine suppliesCargo handler SATS invests S$1m in equipment to handle COVID-19 vaccine suppliesCoronavirus rampant: How deadly is Delta? | To The PointCoronavirus rampant: How deadly is Delta? | To The PointCOVID-19 home test developed in Brisbane approved for emergency use in US | ABC NewsCOVID-19 home test developed in Brisbane approved for emergency use in US | ABC NewsPfizer details its coronavirus vaccine distributionPfizer details its coronavirus vaccine distributionHow 10 Million Vaccine Doses A Day Could Be Shipped From Chicago O'hare Airport | Big BusinessHow 10 Million Vaccine Doses A Day Could Be Shipped From Chicago O'hare Airport | Big BusinessAus COVID vaccine trials abandoned. What does this mean for Australia's vaccine program? | ABC NewsAus COVID vaccine trials abandoned. What does this mean for Australia's vaccine program? | ABC NewsWhite Fungus cases found in India - Why White Fungus is deadlier than Black Fungus?White Fungus cases found in India - Why White Fungus is deadlier than Black Fungus?Your Queries Answered: Do People Recovered From Covid Too Need The Vaccine?Your Queries Answered: Do People Recovered From Covid Too Need The Vaccine?Families grieve as COVID-19 deaths surge in the US | 7.30Families grieve as COVID-19 deaths surge in the US | 7.30‘Part of COVID Vaccine ‘Covaxin’ Trials, Here’s My Experience’ | The Quint‘Part of COVID Vaccine ‘Covaxin’ Trials, Here’s My Experience’ | The QuintFormer FDA chief Scott Gottlieb on challenges of distributing the Covid-19 vaccine in the U.S.Former FDA chief Scott Gottlieb on challenges of distributing the Covid-19 vaccine in the U.S.First Severe Reaction To Covid Vaccine Reported In U.S. | NBC Nightly NewsFirst Severe Reaction To Covid Vaccine Reported In U.S. | NBC Nightly News
Яндекс.Метрика